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Widespread changes in mRNA stability
contribute to quiescence-specific gene
expression patterns in a fibroblast model of
quiescence
Elizabeth L. Johnson1, David G. Robinson2 and Hilary A. Coller3,4*
Abstract
Background: Quiescence, reversible exit from the cell division cycle, is characterized by large-scale changes in
steady-state gene expression, yet mechanisms controlling these changes are in need of further elucidation. In order
to characterize the effects of post-transcriptional control on the quiescent transcriptome in human fibroblasts, we
determined mRNA decay rates for over 10,000 genes using a transcription shut-off time-course.
Results: We found that ~500 of the genes monitored exhibited significant changes in decay rate upon quiescence
induction. Genes involved in RNA processing and ribosome biogenesis were destabilized with quiescence, while genes
involved in the developmental process were stabilized with quiescence. Moreover, extracellular matrix genes
demonstrated an upregulation of gene expression that corresponded with a stabilization of these transcripts.
Additionally, targets of a quiescence-associated microRNA (miR-29) were significantly enriched in the fraction
of transcripts that were stabilized during quiescence.
Conclusion: Coordinated stability changes in clusters of genes with important functions in fibroblast quiescence
maintenance are highly correlated with quiescence gene expression patterns. Analysis of miR-29 target decay rates
suggests that microRNA-induced changes in RNA stability are important contributors to the quiescence gene expression
program in fibroblasts. The identification of multiple stability-related gene clusters suggests that other posttranscriptional
regulators of transcript stability may contribute to the coordination of quiescence gene expression. Such regulators may
ultimately prove to be valuable targets for therapeutics that target proliferative cells, for instance, in cancer
or fibrosis.
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Background
Cellular quiescence is a state of cell cycle arrest that
is characterized by the unique ability of cells to exit
and re-enter the cell division cycle upon presentation
of the appropriate stimulus. The proliferation of
B-cells during an immune response, hepatic stellate
cells in response to liver injury, and skin fibroblasts
during wound healing all rely on the ability of cells
to properly re-enter the cell cycle from a quiescent
state [1–3]. Upon induction to the quiescent state,
there are well-documented changes in gene expres-
sion, but the regulation and coordination of gene
expression changes with quiescence is not fully
understood [4–6]. Transcriptional repressors such as
HES1 and FOXC1 that can control the expression of
clusters of genes involved in maintaining the revers-
ibility of quiescence have been shown to account for
some of these observed expression changes [5, 7, 8].
In addition to transcriptional control, post-transcriptional
contributions to quiescence gene regulation have the
potential to have large effects on the quiescence gene
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expression signature. During quiescence, downregulation
of cell cycle progression-promoting genes such as the
transcription factor MYC is important for sustaining
cell cycle exit. A transcript-stabilizing truncation
containing an AU-rich element (ARE) in the MYC
3’UTR can lead to cell cycle misregulation and onco-
genic transformation [9]. Moreover, RNA binding
proteins that elicit decay through interactions with
AREs have been shown to be necessary in maintain-
ing lymphocyte quiescence [10]. Additionally, upreg-
ulation of cell cycle progression inhibitors like the
cyclin-dependent kinase inhibitor CDKNIB (p27
(Kip1)) is required for cell cycle exit and CDKN1B
has been shown to be extensively post-transcriptionally
regulated [11, 12].
Post-transcriptional regulatory mechanisms are
emerging as major contributors to the biological func-
tions essential to quiescence biology. Directly deter-
mining the stability of mRNA transcripts has multiple
advantages over steady-state determinations of gene
expression for understanding contributions of post-
transcriptional control to gene regulation. One advan-
tage is that RNA stability measurements increase the
ability to identify clusters of genes that are controlled
by a common post-transcriptional regulator [13, 14].
In a lymphocyte model of quiescence, it was shown
that around 50% of the gene expression changes
observed upon activation to proliferation were
controlled at the level of RNA stability [15, 16]. Add-
itionally, microRNAs, which can act as posttranscrip-
tional negative regulators of gene expression, have
been shown to have effects on transcript stability
[17]. Thus, clustering transcripts by changes in stabil-
ity can give greater resolution to the identification of
miRNAs important for stability-based changes in gene
expression rather than using steady state gene expres-
sion measurements for these inferences. Coupling
stability measurements with steady-state gene expres-
sion measurements gives more information on how
the steady state was reached and how future pertur-
bations may affect the potential to reach a new steady
state. This information is lost when solely analyzing
gene expression data [18].
In this study, we characterized changes in mRNA stabil-
ity between proliferating and quiescent fibroblasts using
genome-wide measurements of mRNA stability. Analysis
of these measurements revealed stability-regulated gene
clusters with shared biological functions. Concurrent
measurements of steady-state gene expression allowed
more insight into how up and down regulated gene clus-
ters were affected by changes in RNA stability. Notably, a
stability-regulated cluster was defined by targets of the
quiescence-associated miRNA, miR-29, giving further
insight into its mechanism of action.
Results
Genome-wide changes in RNA stability with quiescence
induction
To understand the global role of post-transcriptional
control in the regulation of the quiescent transcriptome,
we used microarrays to determine half-lives of over
10,000 transcripts in human foreskin fibroblasts. Tran-
scription was inhibited in either proliferating (P) cells or
cells made quiescent by 7 days of contact inhibition of
growth (CI7). Samples were collected over an 8 h time
period and analyzed by microarray. Decay constants
were calculated by fitting the log decrease in transcript
abundance to a linear model and genes with a poor fit to
the linear model were filtered from further analysis (see
Methods). Correlations of decay constants with
publically available data sets were in good concordance
with previous calculations in other cell culture models
(Additional file 1).
To identify differentially post-transcriptionally regu-
lated genes between P and CI7 fibroblasts, we focused
on the 485 genes that had significant changes in
transcript stability between the two states (Fig. 1a).
Genes were identified as having significantly different
decay rates if time course fluorescence intensities had a
significantly different slope, according to an ANOVA
F-test, comparing P and CI7 conditions (FDR < 0.05, see
Methods).
K-means clustering of decay constants across time
course replicates resulted in two main profiles of
stability changes (Fig. 1a). Genes in cluster 1 exhib-
ited faster decay during quiescence and were enriched
for genes involved in RNA processing and ribosome
biogenesis. Genes in cluster 2 exhibited faster decay
during proliferation and were enriched in genes
involved in developmental processes and anatomical
structure development.
Genes with no significant change in RNA stability
measurements between P and CI7 fibroblasts were
also characterized by enrichments in Gene Ontology
(GO) terms. The GO terms identified shared similar-
ity to those reported in previous studies of transcript
decay rates in human cells [19, 20]. Fast-decaying
transcripts in both states were enriched for GO terms
such as “regulation of gene expression”, while slow-
decaying transcripts in both states were enriched for
ontology terms related to “cellular respiration”. A full
list of clustered decay rate distributions and
corresponding enriched GO terms is included in
Additional file 2, Additional file 3: Figure S1, and
Additional file 4. Gene set enrichment analysis of
genes with significant changes in RNA stability
provided further resolution of stability-regulated
quiescence gene sets. Top sets with faster decay dur-
ing quiescence included mitochondrial translation,
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DNA damage response, and RNA-related processes
(Additional file 3: Figure S2A). In contrast, top sets
with slower decay during quiescence included genes
involved in differentiation and extracellular matrix
disassembly (Additional file 3: Figure S2B).
Changes in RNA stability correlate with a subset of gene
categories that have large changes in gene expression
during quiescence
In order to better understand how these genome-wide
changes in RNA stability are associated with gene
expression, we looked for correlations between mRNA
stability changes and changes in steady-state gene expres-
sion upon quiescence induction. We profiled gene expres-
sion in P versus CI7 fibroblasts using Agilent two-color
microarrays to understand the contribution of RNA stabil-
ity to changes in gene expression. There was no overall
correlation between changes in expression and stability of
the genes common between the two datasets. However,
there were groups of genes that had well-defined changes
in stability that were correlated with large changes in
steady-state gene expression levels. Notably, the majority
of the most strongly upregulated genes in the quiescent
state log2
CI7Abundance
PAbundance
 
> 2
 
were preferentially stabilized
with quiescence (Fig. 2a). These genes were enriched for
extracellular matrix (ECM) organization genes. Included
in this cluster of genes are multiple genes that encode col-
lagens including COL14A1 and COL15A1, which have
well-defined roles in ECM creation and can be overex-
pressed during fibrosis [21–23]. Among the most
strongly downregulated genes in the quiescent state
log2
CI7Abundance
Pabundance
 
< −2
 
, the majority of genes were also
preferentially stabilized during quiescence (Fig. 2b). These
genes expressed at lower levels in proliferating cells and
exhibiting more rapid decay in proliferating cells included
the critical cell cycle regulator CDC25A.
miR-29 targets involving extracellular matrix are stabilized
during quiescence
To identify potential regulators responsible for a coordi-
nated change in the stability and expression of genes, we
Fig. 1 Genes that change in RNA stability with quiescence are related in function. Heatmap showing the changes in RNA stability between proliferating
(P) and 7-day contact inhibited fibroblasts (CI7). Columns 1 and 2 are biological replicates of mean centered decay rate constant determinations in P fibroblasts
and columns 3 and 4 are replicates of decay rate constant determinations in CI7 fibroblasts. Positive values (yellow) indicate slower decay compared to the
mean rate for that gene while negative values (blue) indicate that genes have faster decay compared to the mean rate for that gene. Values were clustered
into two unique groups using the k-means algorithm. Gene ontology terms that are significantly enriched in a cluster are marked to the
right of the heatmap. Decay profiles of representative genes from each cluster are displayed below the heatmap
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used predicted miRNA targets from TargetScan [24] as
gene set references and identified gene sets for which
the differences in corrected decay constants (see
Methods) between conditions were different for the
genes in each miRNA target set as compared to genes
outside of the target set [25]. This analysis allowed us to
identify miRNA targets enriched in categories of genes
that were stabilized or destabilized in the quiescent state
(Fig. 3). Out of the 485 differentially stabilized tran-
scripts, mRNA targets of miR-29, let-7, miR-137, and
miR-130 were stabilized with quiescence while miR-17
and miR-200 targets were stabilized with proliferation.
We decided to focus on miR-29 targets based on our
previous demonstration that miR-29 plays an important
functional role in quiescence [26]. miR-29 targets are
significantly stabilized with quiescence, and are enriched
for genes that encode proteins that are found in the
ECM or are involved in ECM remodelling. In our previ-
ous study, targets of the miR-29 family were more likely
to change in abundance with quiescence than the targets
of any other microRNA investigated [26]. Downregula-
tion of miR-29 during quiescence resulted in a relief of
negative regulation of these miR-29 targets, and thus,
they are expressed at higher levels in quiescent than pro-
liferating cells. In this current analysis, targets of the
miR-29 family (miR-29abcd) were significantly more
stable during quiescence (χ2, 1, p < 0.05). The decay and
gene expression profiles of computationally-predicted
Fig. 2 Gene expression and RNA stability heatmap for the top upregulated a and downregulated b genes with quiescence. Columns 1 and 2 are
the log2 fold change in gene expression with quiescence log2
CI7Abundance
PAbundance
  
from microarray gene expression profiling of 7-day contact inhibited
(CI7) and 14-day contact inhibited (CI14) fibroblasts. Column 3 is the log difference in decay constants (KD proliferation − KD quiescence) shrunken
by the local false discovery rate (see Methods) scaled to fit within the bounds of the gene expression values between CI7 and P fibroblasts. Gene
ontology terms that are significantly enriched in a cluster are marked to the right of the heatmap
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miR-29 collagen-related targets show a strong pattern of
stabilization of miR-29 targets in the quiescent state, and
higher expression of the associated genes in the quies-
cent compared with the proliferating state (Fig. 4a).
Since miRNA target prediction can include many false
positives and targets that are only regulated in specific
biological contexts, we refined this target set even fur-
ther by focusing on the specific transcripts that we
found to be regulated when miR-29 was introduced into
primary human dermal fibroblasts [26]. We observed
that experimentally-validated miR-29 targets exhibited
an even stronger gene expression-stability signature of
upregulation of gene expression and transcript
stabilization with quiescence than the set of computa-
tionally predicted targets (Fig. 4b). In summary, miR-29
levels decrease with quiescence and this relief of nega-
tive regulation correlates with our observation of
increased stability of miR-29 targets. By monitoring tran-
script decay rates, we can now conclude that the
observed miR-29 regulation of quiescence targets reflects
changes in mRNA stability.
Discussion
In a fibroblast model of quiescence, we observed that
RNA stability, an important mechanism for post-
transcriptional regulation, changes on a genome-wide
scale during quiescence. Defining whether the expression
levels of a transcript are controlled by transcriptional or
post-transcriptional mechanisms can provide further
insight into the mechanisms underlying coordinated
changes in gene expression. Our findings are consistent
with other reports that transcript stability can be an im-
portant contributor to changes in cell fate [14, 27, 28]. For
instance, in differentiating C2C12 cells, there were
changes in transcript decay during differentiation to a
myoblast phenotype that were closely associated with
changes in gene expression [27]. Additionally, in lympho-
cytes, transcript decay rates were shown to be critical for
the sequential waves of gene expression events that occur
upon activation [28]. In our study of proliferating versus
quiescent fibroblasts, there was no overall correlation
between mRNA abundance and decay rate. With a more
focused analysis on genes with the most significant in-
crease or decrease in expression, we were able to deter-
mine that extracellular matrix genes were characterized by
slower decay rates and a higher abundance in quiescent
compared with proliferating cells.
Extracellular matrix metabolism genes, which are
highly upregulated during quiescence, exhibit increased
transcript stability in the quiescent state compared to
the stability of these same genes when fibroblasts are
proliferating. Such findings would be consistent with an
important role for skin fibroblasts in synthesizing colla-
gen that forms the connective tissue in skin. These data
suggest that the changes in collagen and extracellular
matrix production are controlled, at least in part, post-
transcriptionally at the level of mRNA stability. This
insight into gene regulation is masked when profiling
steady state levels of gene expression, but when RNA
stability is also profiled, more insight into the mechanis-
tic coordination of related gene sets is gained. Moreover,
miR-29, a negative regulator of collagen gene expression,
is downregulated during quiescence induction. Upregu-
lation of miR-29 during proliferation leads to negative
regulation of these same transcripts, which share a com-
mon biological function, by decreasing their stability.
Global changes in miRNA abundance have been docu-
mented in multiple mammalian quiescence models [26, 29, 30]
Fig. 3 miRNAs with targets enriched for differential stability between proliferating and 7 day contact-inhibited fibroblasts. Violin plots display the
distribution of the difference in decay rates for the targets of miRNAs with significant enrichment of stabilized or destabilized targets with quiescence.
The difference in decay constants between P and CI7 fibroblasts (Pconstant – CI7constant) is displayed on the x-axis. The number of transcripts in the distribution
is displayed in parentheses after the miRNA family name on the y-axis
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and contribute to regulatory networks necessary for defin-
ing and maintaining cell cycle phenotypes [31, 32]. Differ-
ences in corresponding RNA binding protein complexes
[33] and transcript architecture [34] during quiescence
can lead to different mechanisms of miRNA-dependent
transcript regulation. Cell-cell contact was reported to
enhance miRNA processing, resulting in increased
miRNA biogenesis and more efficient formation of RNA-
induced silencing complexes [29]. When considering
miRNA-dependent effects on RNA stability, this model
suggests that there might be rapid decay of miRNA targets
in quiescent cells. In another study, miRNAs have been
reported to be stored in inactive low molecular weight
Argonaute protein complexes that lack GW182 in a quies-
cence model [33]. These findings suggest that miRNA
target genes might be more stable in the quiescent state.
Fig. 4 Gene expression and stability change heatmap for collagen-related miR-29 targets. Gene expression and RNA decay constant changes for
computationally predicted a and experimentally validated b miR-29 targets. Black bars on the bottom of the heatmap mark the columns that are
changes in gene expression while the last column is the log of the change in decay constant between P and CI7 fibroblasts. Gene expression
columns show the log2 fold change in gene expression between P and CI7 fibroblasts log2
CI7Abundance
PAbundance
  
. Decay columns are the log difference in
decay constants (KD proliferation− KD quiescence) shrunken by the false discovery rate scaled to fit within the bounds of the gene expression
values between CI7 and P fibroblasts (see Methods) between CI7 and P fibroblasts. Gene names are to the right of the heatmap
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Our data identified examples of both cases where a
portion of miRNA targets were more stable during quies-
cence (including miR-29 targets), and a portion of targets
were less stable during quiescence. These results are
consistent with our own analysis in which the levels of
miRNAs were monitored by microarray and miR-29 levels
were discovered to decline relative to other miRNAs in
quiescent cells [26]. The results are also consistent with
our findings that miR-29 hastens cell cycle re-entry from
quiescence [26].
miRNA-dependent alterations of transcript stability
[17, 35, 36] and translational efficiency [37] have both
been identified as contributors to gene regulatory
changes and this work adds to our understanding of
the role of miRNAs in the regulation of transcript
stability changes between cell cycle states. Our ana-
lysis of miRNA targets enriched for differential decay
between P and CI7 fibroblasts highlight a potential
role for the miR-17-92 cluster, and miR-200 in pro-
moting transcript decay in quiescent cells, and miR-
130 in promoting transcript decay in proliferating
cells. Moreover, the miR-17-92 cluster in particular
has been previously implicated in cell cycle regulation
[38, 39]. These microRNAs are candidates for further
study as potential regulators of the proliferation-
quiescence transition.
Our work further defines a role for specific changes in
transcript stability as contributors to gene regulation in
a fibroblast quiescence model. Regulators of gene
expression such as miR-29 serve as candidate targets for
affecting the expression of extracellular matrix expres-
sion, for instance, in fibrotic disease.
Conclusion
This study provides a rich set of data to add to the grow-
ing knowledge about how mRNA stability contributes to
gene expression changes as a cell responds to various
stimuli. We were able to integrate data on mRNA tran-
script stability, mRNA transcript abundance and miRNA
expression to better understand how genes involved in
extracellular matrix metabolism are regulated during
fibroblast quiescence. Further studies elucidating the
role of RNA biology in fibroblast quiescence will
improve our understanding of complex proliferative and
secretory diseases such as fibrosis.
Methods
Cell culture and transcription shutoff time course
Human fibroblasts were isolated from the dermal layer
of neonatal foreskin tissue as previously described [40].
Proliferating and contact-inhibited fibroblast were main-
tained in DMEM supplemented with 10% fetal bovine
serum (FBS). Proliferating cells were seeded at 5 × 105
cells per 10 cm plate and split every 48 h. Contact-
inhibited cells were seeded at 5 × 105 cells per 10 cm
plate with medium changes every 48 h until the end of a
7-day time period.
To inhibit transcription in proliferating and 7-day
contact-inhibited fibroblasts, actinomycin D was added
to the culture media at a concentration of 15 μg/mL.
Cells were washed with PBS and cell lysates were
collected using Trizol (Life Technologies) at 0, 120, 240,
and 480 min after addition of actinomycin D.
Decay rate constant calculations
Based on the first order nature of mRNA decay kinetics,
fluorescence intensities were log-transformed and fit to
a linear decay model, using time, cell cycle condition (P
or CI7), and biological replicate as predictors. Genes
with a poor fit to the log linear decay model (6297 of
14212 total transcripts, ANOVA F-test, p > 0.05) were
filtered from subsequent analysis. Transcripts with a
significant interaction term between condition and time,
according to an ANOVA F-test (FDR < 0.05), were
considered to have different decay rates between P and
CI7 fibroblasts. To aide in the interpretation of changes
in decay between states, a metric (decay metric) to
compare P to CI7 decay constants was calculated by
taking the difference between the P and CI7 decay con-
stants and using the local False Discovery Rate [41] to
bring the value of constant comparisons without a
significant change between conditions towards 0. All
original intensities and calculated values are available in
Additional file 4.
Microarray labeling, hybridization, and raw data
processing
RNA was isolated from Trizol lysates according to the
manufacturer’s protocol [42]. RNA quality was verified
on a Bioanalyzer 2100 using reagents from the RNA
nano 6000 kit (Agilent Technology). RNA that passed
quality and yield cutoffs were reverse transcribed into
cDNA and subsequently labelled with the dye Cyanine-3
through the transcription of cRNA using the Quick
Amp Microarray Labelling Kit (Agilent Technology).
RNA spike-in control A (Agilent Technology) was added
to each RNA sample in the time course at equal
amounts as a control for labelling and hybridization
efficiency. Labeled cRNA was hybridized to Human 4 ×
44 K gene expression microarrays using the one-color
format for 17 h at 65 °C (Agilent Technology). Fluores-
cence intensities were detected using a microarray
scanner (Agilent Technology) and assigned to the appro-
priate gene using Feature Extractor 6.1 (Agilent
Technology) software. Probes with fluorescent intensities
above background and above Feature Extractor quality
control thresholds were used in decay rate constant
determinations.
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Microarray cRNA transcription and hybridization
Total RNA samples from P, CI7, and CI14 cells were
reverse transcribed into cDNA and fluorescently labeled
with Cyanine 3-CTP (CY3) (quiescent samples) or
Cyanine 5-CTP (CY5) (proliferating samples) to make
cRNA according to the manufacturer’s protocol for the
Quick Amp Labeling Kit for Microarray Analysis
(Agilent). cRNA samples that passed yield and labeling
standards were fragmented and proliferating and quies-
cent samples were hybridized to Human gene expression
4 × 44 K arrays (Agilent) for 17 h at 65 °C in an oven ro-
tating the arrays at 10 rpm.
Fluorescence intensities were detected using the Genepix
scanner (Agilent) and probe identities were determined
using Agilent’s feature extractor version 11.5. Probes
detected over background fluorescence thresholds were
used in subsequent gene expression analysis. Microarray
data was uploaded to the Princeton University MicroArray
database (PUMAdb) and is accessible for download with
the proper permissions. Log2 ratios of quiescent versus pro-
liferating gene expression are available in Additional file 5.
Gene ontology analysis and miRNA enrichment analysis
Overrepresentation of gene ontology terms in gene clus-
ters defined by k-means clustering of decay constants was
determined using the Lewis-Sigler Gene Ontology tool
(http://go.princeton.edu/). miRNA enrichment was calcu-
lated by collecting the predicted TargetScan [24] targets of
each miRNA, then using a Wilcoxon rank-sum test to
compare differences in decay constants Pconstant – CI7con-
stant within the set to genes outside the set [25]. Enrich-
ment tests and violin plots displaying the differences in
decay constants Pconstant – CI7constant for targets of each
miRNA were performed using the GSEAMA package
(David Robinson – Princeton University) implemented in
R. The difference in decay constants between P and CI7
fibroblasts from miR-29 targets were compared to non--
targets using a Chi-squared test for independence to test
whether miR-29 targets versus non-targets had a higher
proportion of genes that decayed faster during
proliferation as compared to quiescence.
Additional files
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Additional file 2: Gene ontology tables of genes with fast or slow
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separated by k-means clusters. Figure S2A. Gene set enrichment
analysis of genes destabilized with quiescence. Figure S2B. Gene set
enrichment analysis of genes stabilized with quiescence (2.7 mb).
(PDF 2619 kb)
Additional file 4: Decay time course microarray fluorescence intensities,
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results. (XLSX 7664 kb)
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